Tech Company Financing Transactions
Optellum Funding Round
On 9/27/2022, Optellum announced $14 million in Series A funding from Mercia Fund Management, Black Opal Ventures and Intuitive Venture Partners.
Transaction Overview
Company Name
Announced On
9/27/2022
Transaction Type
Venture Equity
Amount
$14,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to scale its base, operations, and commercial launches in the UK and USA; accelerate research and development; and expand its platform into personalized therapy decisions by integrating imaging data with molecular data, robotics, and liquid biopsies.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Oxford Centre for Innovation
Oxford, OX1 1BY
UK
Oxford, OX1 1BY
UK
Phone
Undisclosed
Website
Email Address
Overview
Optellum was founded so that every lung disease patient is diagnosed and treated at the earliest possible stage, and cured. Our vision is to redefine early intervention of diseases like lung cancer, by enabling every clinician, in every hospital, to make the right decisions and give their patients the best chance to fight back.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jason Pesterfield
Chief Financial Officer
Kirk Jacquay
Co-Founder
Timor Kadir
Co-Founder
Lyndsey Pickup
Co-Founder
Vaclav Potesil
Browse more venture capital transactions:
Prev: 9/27/2022: Dalan Animal Health venture capital transaction
Next: 9/27/2022: Smart Token Labs venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs